The HCPLive Cardiology condition center page is a comprehensive resource for clinical news and insights on cardiovascular and cardiometabolic diseases. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for heart disease and cardiovascular events, as well as associated diabetes, renal failure, and more...
October 25th 2024
New research indicates semaglutide reduced albuminuria and body weight in CKD patients without diabetes, highlighting its potential renal benefits.
Elevating Care for PAH: Applying Recommended Management Approaches to Maximize Outcomes
View More
‘REEL’ Time Patient Counseling™: Navigating the Complex Journey of Diagnosing and Managing Fabry Disease
View More
Expert Illustrations & Commentaries™: Envisioning Novel Therapeutic Approaches to Managing ANCA-associated Vasculitis
View More
Piotr Slomka from Cedars-Sinai: Can Machines Replace Humans in Test Interpretation?
Across the spectrum of medicine machines are being trained to play a larger role in the diagnosis and treatment process. A recent study looked at whether machines are better at predicting the future for a patient and their overall care.
Experts Debunk Myths Surrounding Testosterone Deficiency and Treatment
In recent years, there have been questions raised about the true dangers of testosterone deficiency (TD) and the efficacy and side effects of testosterone therapy, particularly as they pertain to patients who are at risk for cardiovascular disease and prostate cancer.
High Doses of Imodium Cause Serious Heart Problems, FDA Warns
Over-the-counter diarrhea drug loperamide (Imodium/Johnson & Johnson Consumer Inc.) has recently been in the news because opioid abusers have been using it to self-treat symptoms of opioid withdrawal. Others abuse it for its euphoric properties.
Metabolic Surgery is Now a Recommended Treatment for Obese Patients with Type 2 Diabetes
New consensus guidelines for the treatment of type 2 diabetes mellitus (T2DM) recommend, for the first time, that metabolic surgery be recommended or considered as an intervention for many obese patients.
Many Women and Elderly Patients Receive Inadequate Treatment for AFib-Related Stroke Prevention
Study results show that women with atrial fibrillation are less likely to receive recommended thromboprophylaxis medications than men, and patients age 85 and older are often treated with aspirin as the sole antithrombotic agent.
Diana Wolfe: Protecting Fetus Health While Treating the Mother Effectively
When treating a woman for cardiac issues in pregnancy there can be potential risks to the fetus. As more is learned about these conditions doctors are better able to help deliver as healthy a baby as possible.
Stem Cell-Derived Beta-Cells Offer Potential Novel Treatment Approaches for Type 1 Diabetes
Investigators from Washington University and Harvard University have used stem cells derived from patients with type 1 diabetes mellitus to produce cells that secrete insulin in both cultures and mice.
Marie McDonnell from Brigham & Women's Hospital: Crossing Over from Endocrinology to Cardiology
When treating patients with a variety of conditions it can be easy for the lines of care to be blurred, this is particularly true when treating patients with conditions like diabetes and heart failure among others.